Other pharmaceutical giants have taken notice at Ozempic/Wegovy's weight loss success and are jumping in to the market.
. All were randomly assigned to receive weekly injections of either CagriSema, cagrilintide alone or semaglutide alone, for eight months.control was improved with the combo drug versus either drug alone, wrote a team that was also led by Frias., by the end of the trial people taking CagriSema lost an average 15.6% of weight, compared to 8.1% taking cagrilintide alone and 5.1% of those taking only semaglutide, Frias' team reported.
"I want to highlight how exciting this field is right now. We've never before had medications that have been this effective, so it's really exciting," said Dr. Katherine Saunders, an internist with Weill Cornell Medicine in New York City and a spokeswoman for The Obesity Society. "Obesity is such a complex, heterogeneous disease, so it's not going to be that one medication is the answer for everybody.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A new pill may work as well as Ozempic and Wegovy shots to treat obesityNew research released Sunday shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes
Read more »
New pill forms of Ozempic, Wegovy a diabetes and weight-loss ‘game-changer’If approved, the new pill forms of semaglutide could revolutionize the fast-changing weight-loss landscape.
Read more »
A daily pill may work as well as Ozempic, Wegovy shots to treat obesity: studyNew research released Sunday shows high-dose oral versions of the medication in the blockbuster drugs may work as well as injections — even in hard-to-treat people with diabetes.
Read more »
No More Shots: Pill Versions of Ozempic-Like Drugs Are ComingTablets could appeal to people who want to lose weight but despise needles, which injections like Ozempic require.
Read more »
Pfizer to end development of experimental obesity pill due to elevated liver enzymesPfizer's two pills are part of the same class of obesity drugs as Novo Nordisk's blockbuster weight loss injections Ozempic and Wegovy.
Read more »
Ozempic-Wegovy pill may be on the way: Trial shows promising results for new weight loss tabletA tablet form of semaglutide for weight loss showed positive results in phase 3 clinical trials, researchers announced at the American Diabetes Association (ADA) Scientific Session in Los Angeles, California.
Read more »